- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-FGD5/ ZFYVE23 monoclonal antibody
Anti-FGD5/ ZFYVE23 antibody for FACS & in-vivo assay
Go to FGD5/FGD5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-MP2122-Ab-1/ GM-Tg-hg-MP2122-Ab-2 | Anti-Human FGD5 monoclonal antibody | Human |
| GM-Tg-rg-MP2122-Ab-1/ GM-Tg-rg-MP2122-Ab-2 | Anti-Rat FGD5 monoclonal antibody | Rat |
| GM-Tg-mg-MP2122-Ab-1/ GM-Tg-mg-MP2122-Ab-2 | Anti-Mouse FGD5 monoclonal antibody | Mouse |
| GM-Tg-cynog-MP2122-Ab-1/ GM-Tg-cynog-MP2122-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FGD5 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-MP2122-Ab-1/ GM-Tg-felg-MP2122-Ab-2 | Anti-Feline FGD5 monoclonal antibody | Feline |
| GM-Tg-cang-MP2122-Ab-1/ GM-Tg-cang-MP2122-Ab-2 | Anti-Canine FGD5 monoclonal antibody | Canine |
| GM-Tg-bovg-MP2122-Ab-1/ GM-Tg-bovg-MP2122-Ab-2 | Anti-Bovine FGD5 monoclonal antibody | Bovine |
| GM-Tg-equg-MP2122-Ab-1/ GM-Tg-equg-MP2122-Ab-2 | Anti-Equine FGD5 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-MP2122-Ab-1/ GM-Tg-hg-MP2122-Ab-2; GM-Tg-rg-MP2122-Ab-1/ GM-Tg-rg-MP2122-Ab-2; GM-Tg-mg-MP2122-Ab-1/ GM-Tg-mg-MP2122-Ab-2; GM-Tg-cynog-MP2122-Ab-1/ GM-Tg-cynog-MP2122-Ab-2; GM-Tg-felg-MP2122-Ab-1/ GM-Tg-felg-MP2122-Ab-2; GM-Tg-cang-MP2122-Ab-1/ GM-Tg-cang-MP2122-Ab-2; GM-Tg-bovg-MP2122-Ab-1/ GM-Tg-bovg-MP2122-Ab-2; GM-Tg-equg-MP2122-Ab-1/ GM-Tg-equg-MP2122-Ab-2 |
| Products Name | Anti-FGD5 monoclonal antibody |
| Format | mab |
| Target Name | FGD5 |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-FGD5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species FGD5/ ZFYVE23 VLP (virus-like particle) (Products Developing) |
| ORF Viral Vector | vGMLV000021 | human FGD5 Lentivirus particle |
| ORF Viral Vector | pGMLV000021 | human FGD5 Lentivirus plasmid |
Target information
| Target ID | GM-MP2122 |
| Target Name | FGD5 |
| Gene ID | 152273,232237,362402,702022,484640,101100875,539766,100055962 |
| Gene Symbol and Synonyms | C330025N11Rik,FGD5,mFLJ00274,ZFYVE23 |
| Uniprot Accession | Q6ZNL6 |
| Uniprot Entry Name | FGD5_HUMAN |
| Protein Sub-location | Transmembrane Protein |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000154783 |
| Target Classification | N/A |
The target: FGD5, gene name: FGD5, also named as ZFYVE23. Predicted to enable guanyl-nucleotide exchange factor activity and small GTPase binding activity. Predicted to be involved in several processes, including filopodium assembly; regulation of GTPase activity; and regulation of cell shape. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
